Predicting Treatment Outcomes for Malaria in Papua New Guinea
Author Information
Author(s): Jutta Marfurt, Ivo Müller, Albert Sie, Olive Oa, John C Reeder, Thomas A Smith, Hans-Peter Beck, Blaise Genton
Primary Institution: Papua New Guinea Institute of Medical Research
Hypothesis
The study investigates the association between infecting genotype and treatment response to identify predictors of treatment failure with AQ+SP.
Conclusion
The study provides evidence for high levels of resistance to the combination regimen of AQ+SP in PNG and indicates useful molecular markers for monitoring resistance.
Supporting Evidence
- Day-28 treatment failure rates for AQ+SP were 29% in Karimui and 19% in South Wosera.
- pfmdr1 N86Y and pfdhps A437G were identified as strong independent predictors for treatment failure.
- High levels of resistance to AQ+SP were observed in the studied populations.
Takeaway
Researchers looked at how certain genes in malaria parasites affect how well treatments work, finding that some genes can predict if a treatment will fail.
Methodology
The study assessed in vivo treatment failure rates and characterized molecular drug resistance markers in pre-treatment samples.
Potential Biases
Potential biases may arise from the selection of study sites and patient demographics.
Limitations
The study may not account for all factors affecting treatment outcomes, such as host immunity and drug use history.
Participant Demographics
{"age":{"mean":4,"age_range":"6 months to 7 years"},"sex_ratio":{"female":44.3,"male":55.7}}
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 1.03–60.36
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website